|
Dr. Adams has been a director of the Company since 1991. Dr. Adams is the founder and Chairman Emeritus of Genta Inc. a publicly held biotechnology company in the field of antisense technology and since September 1998 has been Chairman of the Board and Chief Executive Officer of Leucadia Technologies a privately held company in the field of medical devices. Before assuming the role of Chairman Emeritus of Genta Inc. in 1997 Dr. Adams served as Genta Inc.'s Chief Executive Officer. Before founding Genta in 1989 Dr. Adams founded Gen-Probe Inc. in 1984 and served as its Chief Executive Officer and Chairman until its acquisition by Chugai Biopharmaceuticals Inc. in 1989. Before founding Gen-Probe and until 1984 Dr. Adams was Senior Vice President of Research and Development at Hybritech. Eli Lilly and Co. later acquired Hybritech in 1986. Dr. Adams has also held management positions at Technicon Instruments and the Hyland Division of Baxter Travenol and served as a Director of Biosite Diagnostics Inc. a publicly held medical research firm from 1989 to 1998. In addition Dr. Adams currently serves as a Director of Invitrogen Inc. a publicly held company that develops manufactures and markets research tools in kit form and other research products and XiFin Inc. and Bio-Mems both private companies. Dr. Adams holds a Ph.D. in Biochemistry from the University of California at Riverside. | 